dinoprost - CISMeF

Preferred Label : dinoprost;

MeSH definition : A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions.;

MeSH synonym : 9alpha,11beta-pgf2; pgf2 alpha; prostaglandin f2 alpha; f2 alpha, prostaglandin; prostaglandin f2alpha; prostaglandin f2; pgf2; f2alpha, prostaglandin; pgf2alpha; 9alpha,11beta pgf2; alpha, pgf2;

MeSH hyponym : estrofan; enzaprost F;

MeSH CAS label : Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-;

MeSH Related Number : 551-11-1 (Dinoprost);

Registry Number MeSH : 551-11-1;

MeSH annotation : do not confuse with DINOPROSTONE; /biosyn /physiol permitted;

Wikipedia link : https://en.wikipedia.org/wiki/Prostaglandin F2alpha;

Is substance : O;

UNII : B7IN85G1HY;

InChIKey : PXGPLTODNUVGFL-YNNPMVKQSA-N;

Details

Origin ID

D015237;

UMLS CUI

C0012471;

ATC code(s)
- dinoprost [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cloprostenol [NCIt concept]
- Product containing dinoprost (medicinal product) [SNOMED CT concept]
- Prostaglandin F2 Alpha Measurement [NCIt concept]
- Prostaglandin F2 alpha [ICHI extension code]
CISMeF manual mappings
- dinoprost [Substance BNPC]
Indexing information
- prostaglandin F2alpha receptor [MeSH Supplementary Concept]
Pharmacological action(s)
- abortifacient agents, nonsteroidal [MeSH Descriptor]
- oxytocics [MeSH Descriptor]
Record concept(s)
- dinoprost [MeSH concept]
- enzaprost F [MeSH concept]
- estrofan [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-ethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate [MeSH Supplementary Concept]
- 1-methyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate [MeSH Supplementary Concept]
- 11-fluoro-11-dehydroxyprostaglandin F2alpha [MeSH Supplementary Concept]
- 11-fluoro-11-deoxyprostaglandin F2alpha [MeSH Supplementary Concept]
- 11-ketotetranorprostaglandin F2alpha [MeSH Supplementary Concept]
- 13,14-dihydroprostaglandin F2alpha [MeSH Supplementary Concept]
- 13,14-dihydroxy-15-ketoprostaglandin F2alpha [MeSH Supplementary Concept]
- 15-fluoro-15-deoxyprostaglandin F2alpha [MeSH Supplementary Concept]
- 15-keto-13,14-dihydroprostaglandin F2alpha [MeSH Supplementary Concept]
- 15-keto-17-phenyl-18,19,20-trinorprostaglandin F2 alpha-1-isopropyl ester [MeSH Supplementary Concept]
- 15-ketoprostaglandin F2alpha [MeSH Supplementary Concept]
- 15-propionat-prostaglandin F2alpha-isopropyl ester [MeSH Supplementary Concept]
- 16,16-dimethylprostaglandin F2alpha [MeSH Supplementary Concept]
- 16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha [MeSH Supplementary Concept]
- 16-aminoprostaglandin F2alpha methyl ester [MeSH Supplementary Concept]
- 16-fluoromethyleneprostaglandin F2alpha [MeSH Supplementary Concept]
- 17-azaprostaglandin F2alpha [MeSH Supplementary Concept]
- 17-phenyl-18,19,20-trinor-prostaglandin F2 alpha-1-isopropyl ester [MeSH Supplementary Concept]
- 17-phenyl-18,19,20-trinorprostaglandin F2 alpha [MeSH Supplementary Concept]
- 17-phenylprostaglandin F2alpha [MeSH Supplementary Concept]
- 18,19,20-trinor-17-cyclohexyl-13,14-dehydroprostaglandin F2alpha methyl ester [MeSH Supplementary Concept]
- 19-hydroxyprostaglandin F [MeSH Supplementary Concept]
- 1a,1b-dihomoprostaglandin F2 [MeSH Supplementary Concept]
- 2,3-dinor-5,6-dihydro-15-F-isoprostane [MeSH Supplementary Concept]
- 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2(alpha) [MeSH Supplementary Concept]
- 2,3-dinor-5,6-dihydroisoprostane F2alpha-III [MeSH Supplementary Concept]
- 2-decarboxy-2-(P-methylphosphinico)-16-phenoxytetranorprostaglandin F(2alpha) [MeSH Supplementary Concept]
- 20-methyl-13,14-(didehydroprostaglandin) F2alpha [MeSH Supplementary Concept]
- 3-(3,5-dihydroxy-2-(oxodecyl)cyclopentyl)propionic acid [MeSH Supplementary Concept]
- 6-keto-prostaglandin F2alpha [MeSH Supplementary Concept]
- 7-(3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)hept-5-enoic acid [MeSH Supplementary Concept]
- 8,12-iso-isoprostane F2alpha-III [MeSH Supplementary Concept]
- 8,12-iso-isoprostane F2alpha-VI [MeSH Supplementary Concept]
- 8-epi-prostaglandin F2alpha [MeSH Supplementary Concept]
- 9-chloro-15-cyclohexyl-11,15-dihydroxy-3-oxa-16,17,18,19,20-pentanor-5-prostenoic acid [MeSH Supplementary Concept]
- AFP-157 [MeSH Supplementary Concept]
- AL 6598 [MeSH Supplementary Concept]
- AL 8810 [MeSH Supplementary Concept]
- AL 8810 ethylamide [MeSH Supplementary Concept]
- AL-3138 [MeSH Supplementary Concept]
- AY 24366 [MeSH Supplementary Concept]
- ICI 79939 [MeSH Supplementary Concept]
- N-dimethylaminoprostaglandin F2alpha [MeSH Supplementary Concept]
- PhXa 85 [MeSH Supplementary Concept]
- ZK 110841 [MeSH Supplementary Concept]
- ZK 118182 [MeSH Supplementary Concept]
- ZK 71677 [MeSH Supplementary Concept]
- delprostenate [MeSH Supplementary Concept]
- dinoprost tromethamine [MeSH Supplementary Concept]
- etiproston [MeSH Supplementary Concept]
- fluprostinol [MeSH Supplementary Concept]
- isopropyl unoprostone [MeSH Supplementary Concept]
- prostaglandin F2 ethyl ester [MeSH Supplementary Concept]
- prostaglandin F2 isopropyl ester [MeSH Supplementary Concept]
- prostaglandin F2 methyl ester [MeSH Supplementary Concept]
- prostaglandin F2alpha 11-methyl ether [MeSH Supplementary Concept]
- prostaglandin F2alpha 15-methyl ether [MeSH Supplementary Concept]
- prostaglandin F2alpha 9-methyl ether [MeSH Supplementary Concept]
- prostaglandin F2alpha N-dimethylamide [MeSH Supplementary Concept]
See also
- F2-Isoprostanes [MeSH Descriptor]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dinoprost [ICD-11 Extension code]
- Dinoprost [NCIt concept]
- Dinoprost (substance) [SNOMED CT concept]
- Product containing dinoprost (medicinal product) [SNOMED CT concept]
- Prostaglandin F2 [LOINC component]
- Prostaglandin F2 alpha [ICD-11 Extension code]
- Prostaglandin F2 alpha [LOINC component]
- Prostaglandin F2alpha [NCIt concept]
- Prostaglandin PGF2 (substance) [SNOMED CT concept]
- dinoprost [ATC Code]
- dinoprost [Substance BNPC]
- dinoprost preparation [SNOMED Notion]
- prostaglandin pgf2 [SNOMED Notion]
- prostaglandin pgf2 alpha [SNOMED Notion]
Validated automatic mappings to BTNT
- dinoprost [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients